Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults (PSC25)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Protein Sciences Corporation
ClinicalTrials.gov Identifier:
NCT01612000
First received: May 7, 2012
Last updated: March 18, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)